Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-087647
Filing Date
2013-03-01
Accepted
2013-03-01 16:03:35
Documents
14
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d453081d10k.htm 10-K 1320459
2 EX-3.2 d453081dex32.htm EX-3.2 195181
3 EX-21.0 d453081dex210.htm EX-21.0 2462
4 EX-23.1 d453081dex231.htm EX-23.1 1691
5 EX-23.2 d453081dex232.htm EX-23.2 1470
6 EX-31.1 d453081dex311.htm EX-31.1 9710
7 EX-31.2 d453081dex312.htm EX-31.2 9698
8 EX-32.0 d453081dex320.htm EX-32.0 5554
  Complete submission text file 0001193125-13-087647.txt   7605236

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT vrml-20121231.xml EX-101.INS 923136
10 XBRL TAXONOMY EXTENSION SCHEMA vrml-20121231.xsd EX-101.SCH 90073
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrml-20121231_cal.xml EX-101.CAL 67962
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrml-20121231_def.xml EX-101.DEF 390438
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrml-20121231_lab.xml EX-101.LAB 623561
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrml-20121231_pre.xml EX-101.PRE 453774
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34810 | Film No.: 13657603
SIC: 2835 In Vitro & In Vivo Diagnostic Substances